Literature DB >> 33512678

Soleal vein dilatation in the early phase of hospitalization is associated with subsequent development of deep vein thrombosis in patients with acute stroke.

Kaima Soga1, Takahiro Shimizu2, Yuta Hagiwara1, Hana Ogura1, Hisanao Akiyama1, Junji Yamauchi3, Tomoo Sato3, Kazuhiko Hanzawa4, Yasuhiro Hasegawa1,5, Yoshihisa Yamano1,3.   

Abstract

PURPOSE: To evaluate the usefulness of soleal vein (SOV) diameter as a predictor of new onset of deep vein thrombosis (DVT) in acute stroke patients.
METHODS: A total of 121 acute stroke patients who were admitted within 48 h of onset underwent a calf vein ultrasonography (CVUS) examination within 7 days after hospitalization. They were evaluated for the presence of DVT and risk factors including maximum SOV diameter. Next, the patients in whom DVT was not detected at the first CVUS examination underwent a second CVUS examination on the 21st hospital day, and were evaluated for the presence of new DVT.
RESULTS: DVT was detected in 27 of 121 patients at the first CVUS examination. A significant association was noted between the presence of DVT and higher levels of soluble fibrin monomer, D-dimer, and C-reactive protein, and a higher rate of having cancer concomitantly. Furthermore, 50 of 94 patients without DVT at the first CVUS examination underwent a second CVUS examination. Of the 94 patients, 44 were excluded, because they were discharged by the 21st day. Note that DVT was newly developed in 12 of the 50 patients who underwent the second CVUS. A significant association was found between the presence of new DVT and the rate of history of stroke, hematocrit level, and maximum SOV diameter at the first examination.
CONCLUSION: In our acute stroke patients, SOV dilation, history of stroke, and elevated hematocrit level were found to be associated with risk of developing a new DVT.

Entities:  

Keywords:  Acute stroke; Deep vein thrombosis; Soleal vein diameter; Ultrasonography

Mesh:

Year:  2021        PMID: 33512678     DOI: 10.1007/s10396-020-01075-x

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  3 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Venous thromboembolism in stroke: literature review and implications for clinical practice.

Authors:  M E Brandstater; E J Roth; H C Siebens
Journal:  Arch Phys Med Rehabil       Date:  1992-05       Impact factor: 3.966

3.  Clinical Risk Factors of Asymptomatic Deep Venous Thrombosis in Patients With Acute Stroke.

Authors:  Yi Wang; Yu Shi; Yi Dong; Qiang Dong; Ting Ye; Kun Fang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.